Monday, March 30, 2026

Nvidia Rebounds with a 3% Surge Amid Tech Stock Rally – Here’s Why

Nvidia's stock surged over 3% amid broader market gains, linked to a drop in CPI and speculation on Fed interest rate cuts.

West Point: America’s Premier Forge of Military Leaders

On July 4, 1802, the United States...

51st Air Control Squadron Honored for Excellence in Combat Power Development

The 51st Air Control Squadron received the Combat Power Development award for enhancing air surveillance and response capabilities.

Tag: cholangiocarcinoma

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us